Ads
related to: acute myeloid leukemia mouth sores- Patient Support Programs
Discover Programs to Help Patients
Access an R/R FLT3m+ AML Treatment.
- About FLT3m+ AML
Review Information on FLT3 Mutation
Positive Acute Myeloid Leukemia.
- Safety Information
View Important Safety Information
for a R/R FLT3m+ AML Treatment.
- Safety Profile
View Adverse Reactions and Safety
Profile of a FLT3m+ AML Treatment.
- Patient Support Programs
bargaininsight.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
Acute myeloid leukemia (AML) is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal cells that build up in the bone marrow and blood and interfere with normal blood cell production. [1] Symptoms may include feeling tired, shortness of breath, easy bruising and bleeding, and increased risk of infection. [1]
Etoposide, sold under the brand name Vepesid among others, is a chemotherapy medication used for the treatments of a number of types of cancer including testicular cancer, lung cancer, lymphoma, leukemia, neuroblastoma, and ovarian cancer. [2] It is also used for hemophagocytic lymphohistiocytosis. [3] It is used by mouth or injection into a ...
Myeloid tissue, in the bone marrow sense of the word myeloid (myelo-+ -oid), is tissue of bone marrow, of bone marrow cell lineage, or resembling bone marrow, and myelogenous tissue (myelo-+ -genous) is any tissue of, or arising from, bone marrow; in these senses the terms are usually used synonymously, as for example with chronic myeloid ...
The underlying pathophysiology of acute myeloid leukemia consist of maturational arrest of the bone marrow cell during the early stages of development. A myeloblast is an immature precursor cell that will change into a monocyte, healthy white blood cell. In AML, Myeloblast do not mature but grow and multiply with regulation.
Transient myeloid leukemia is a pre-leukemic condition. [30] [31] [32] Clonal hematopoiesis is a common age-related phenomenon with a low risk of progression to myelodysplastic syndrome (MDS) and leukemia. [33] Once MDS has developed, the risk of progression to acute leukemia can be assessed using the International Prognostic Scoring System .
Acute myeloid leukemia is a very heterogeneous disease, composed of a variety of translocations and mutations. However, one tenth of all acute myeloid leukemia cases diagnosed have the AML1-ETO fusion oncoprotein due to the t(8;21) translocation. AML1 or RUNX1 is a DNA-binding transcription factor located at the 21q22.
Ads
related to: acute myeloid leukemia mouth soresbargaininsight.com has been visited by 10K+ users in the past month